These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25411324)
1. Treatment comparison in randomized clinical trials with nonignorable missingness: A reverse regression approach. Zhang Z; Cheon K Stat Methods Med Res; 2017 Apr; 26(2):776-795. PubMed ID: 25411324 [TBL] [Abstract][Full Text] [Related]
2. A Two-Step Approach for Analysis of Nonignorable Missing Outcomes in Longitudinal Regression: an Application to Upstate KIDS Study. Liu D; Yeung EH; McLain AC; Xie Y; Buck Louis GM; Sundaram R Paediatr Perinat Epidemiol; 2017 Sep; 31(5):468-478. PubMed ID: 28767145 [TBL] [Abstract][Full Text] [Related]
3. Adjusting for nonignorable missingness when estimating generalized additive models. Xie H Biom J; 2010 Apr; 52(2):186-200. PubMed ID: 20422637 [TBL] [Abstract][Full Text] [Related]
4. Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings. Donneau AF; Mauer M; Lambert P; Molenberghs G; Albert A J Biopharm Stat; 2015; 25(3):570-601. PubMed ID: 24905056 [TBL] [Abstract][Full Text] [Related]
5. A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials. Wu J; Chen MH; Schifano ED; Ibrahim JG; Fisher JD Stat Med; 2019 Dec; 38(30):5565-5586. PubMed ID: 31691322 [TBL] [Abstract][Full Text] [Related]
6. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data. Chen H; Geng Z; Zhou XH Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847 [TBL] [Abstract][Full Text] [Related]
7. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout. Yang M; Maxwell SE Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928 [TBL] [Abstract][Full Text] [Related]
9. Bayesian Two-Part Tobit Models with Left-Censoring, Skewness, and Nonignorable Missingness. Dagne GA; Huang Y J Biopharm Stat; 2015; 25(4):714-30. PubMed ID: 24905924 [TBL] [Abstract][Full Text] [Related]
10. Empirical Likelihood in Nonignorable Covariate-Missing Data Problems. Xie Y; Zhang B Int J Biostat; 2017 Apr; 13(1):. PubMed ID: 28441139 [TBL] [Abstract][Full Text] [Related]
11. Estimation methods for marginal and association parameters for longitudinal binary data with nonignorable missing observations. Li H; Yi GY Stat Med; 2013 Feb; 32(5):833-48. PubMed ID: 22833460 [TBL] [Abstract][Full Text] [Related]
12. A semi-parametric shared parameter model to handle nonmonotone nonignorable missingness. Tsonaka R; Verbeke G; Lesaffre E Biometrics; 2009 Mar; 65(1):81-7. PubMed ID: 18373713 [TBL] [Abstract][Full Text] [Related]
13. Bayesian pattern-mixture models for dropout and intermittently missing data in longitudinal data analysis. Blozis SA Behav Res Methods; 2024 Mar; 56(3):1953-1967. PubMed ID: 37221346 [TBL] [Abstract][Full Text] [Related]
14. Missing not at random models for masked clinical trials with dropouts. Kang S; Little RJ; Kaciroti N Clin Trials; 2015 Apr; 12(2):139-48. PubMed ID: 25627429 [TBL] [Abstract][Full Text] [Related]
15. Generalized additive selection models for the analysis of studies with potentially nonignorable missing outcome data. Scharfstein DO; Irizarry RA Biometrics; 2003 Sep; 59(3):601-13. PubMed ID: 14601761 [TBL] [Abstract][Full Text] [Related]
16. A bivariate pseudolikelihood for incomplete longitudinal binary data with nonignorable nonmonotone missingness. Sinha SK; Troxel AB; Lipsitz SR; Sinha D; Fitzmaurice GM; Molenberghs G; Ibrahim JG Biometrics; 2011 Sep; 67(3):1119-26. PubMed ID: 21155748 [TBL] [Abstract][Full Text] [Related]
17. An index of local sensitivity to nonignorable drop-out in longitudinal modelling. Ma G; Troxel AB; Heitjan DF Stat Med; 2005 Jul; 24(14):2129-50. PubMed ID: 15909292 [TBL] [Abstract][Full Text] [Related]
18. Implementation of pattern-mixture models in randomized clinical trials. Bunouf P; Molenberghs G Pharm Stat; 2016 Nov; 15(6):494-506. PubMed ID: 27658505 [TBL] [Abstract][Full Text] [Related]
19. Modeling missingness for time-to-event data: a case study in osteoporosis. Neuenschwander B; Branson M J Biopharm Stat; 2004 Nov; 14(4):1005-19. PubMed ID: 15587977 [TBL] [Abstract][Full Text] [Related]
20. Identifiability and estimation of causal mediation effects with missing data. Li W; Zhou XH Stat Med; 2017 Nov; 36(25):3948-3965. PubMed ID: 28783880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]